Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05492786 · ClinicalTrials.gov registry record · NA
High-risk Influenza Vaccine Alert
A NA study, sponsored by Geisinger Clinic.
- Completed
- Registry status
- NA
- Development phase
- 80,452
- Enrollment target
NCT05492786 is a NA study that has completed, run by Geisinger Clinic. The registered enrollment target is 80,452 participants.
The verdict
NCT05492786, a NA study, has completed, sponsored by Geisinger Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 80,452 participants
- Enrollment target
Study Summary
The purpose of this study is to assess, prospectively, the effect on flu vaccination rates of salient alerts in the electronic health record that indicate a patient's high risk for flu and its complications. The investigators hypothesize that the salient alerts will lead to increased flu vaccination compared with a standard flu alert.
Interventions
- BEHAVIORAL Alert
- BEHAVIORAL Salient alert features
- BEHAVIORAL High-risk Text
- BEHAVIORAL Risk factors
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80,452 participants |
| Start Date | 2022-09-01 |
| Est. Completion | 2023-04-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05492786
The ClinicalTrials.gov registry entry for NCT05492786 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80,452 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Geisinger Clinic, which has 107 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Alert is the first listed.
NCT05492786 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05492786 about?
NCT05492786 is a clinical study titled "High-risk Influenza Vaccine Alert". The purpose of this study is to assess, prospectively, the effect on flu vaccination rates of salient alerts in the electronic health record that indicate a patient's high risk for flu and its complications. The investigators hypothesize that the salient alerts will lead to increased flu vaccination...
What is the current status of trial NCT05492786?
This trial is currently completed. It is a NA study. The enrollment target is 80,452 participants. The study started on 2022-09-01. Estimated completion is 2023-04-01.
What interventions are being tested in trial NCT05492786?
The interventions under investigation include: Alert (BEHAVIORAL), Salient alert features (BEHAVIORAL), High-risk Text (BEHAVIORAL), Risk factors (BEHAVIORAL).
Who is sponsoring clinical trial NCT05492786?
This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.